Tempus

(Senior) Medical Science Liaison - East New England

Massachusetts, United States

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Biotechnology, PharmaceuticalsIndustries

About Tempus

Passionate about precision medicine and advancing the healthcare industry? Recent advancements in underlying technology have finally made it possible for AI to impact clinical care in a meaningful way. Tempus' proprietary platform connects an entire ecosystem of real-world evidence to deliver real-time, actionable insights to physicians, providing critical information about the right treatments for the right patients, at the right time.

Role Overview

We are looking for a high-performing and experienced Medical Science Liaison (MSL/Sr. MSL) to support Tempus's innovative objectives, including physician support, education on medical advancements, and gathering insights for future developments. We are seeking a field-based MSL with a strong clinical and scientific background in oncology and genomic testing. This role requires excellent communication and presentation skills to educate oncologists, pathologists, and advanced practice providers about Tempus assays and technologies. We are considering candidates residing in CT/RI/MA.

Responsibilities

  • Support commercial team efforts promoting exchange of clinical/scientific/technical information with regional KOLs, community physicians, medical directors, and other HCPs in the field of oncology, including delivering educational presentations, facilitating speaker engagements (live or virtual), and discussions for clinical research.
  • Provide first-class service in clinical science as part of Tempus medical support program to physicians for rapid response to patient NGS test result questions and review of scientific data.
  • Support virtual tumor board presentations to multidisciplinary healthcare provider teams to discuss interesting patient cases regarding targeted therapy and ctDNA monitoring.
  • Provide scientific education for the learning and development of internal stakeholders.
  • Attend conferences and key meetings, to facilitate KOL meetings, provide comprehensive meeting synopses, and summarize high-impact abstracts, posters, and oral presentations.
  • Continuously update internal stakeholders on relevant medical insights.

Required Skills

  • Fundamental understanding of the field of molecular oncology, comprehensive genomic profiling, tumor evolution, and relevant targeted therapy options in early and advanced stage cancer, with ability to interpret clinical trial data.
  • Existing KOL relationships in the field of oncology.
  • Working knowledge of genomic laboratory-developed testing (LDT) with tissue and liquid biopsy; familiarity with CLIA-88’, CAP, Sunshine Act (2013).
  • Proficient public speaking skills with an ability to effectively communicate clinical data and complex scientific concepts.
  • Exceptional interpersonal communication skills, strong inter-, and intradepartmental management skills, ability to educate and train.
  • Self-starter, who can work autonomously to deliver on tight timelines.
  • Ability to travel (up to 50%).

Education and Experience

  • Advanced scientific or medical degree (PhD, PharmD, MD, MSN, BSN)
  • Basic understanding of oncology required; basic understanding of molecular testing strongly preferred.

Preferred Qualifications

  • 1+ years of MSL experience in diagnostics, biotech or pharmaceutical industries.

Employment Type

Full time

Location

Remote - USA

Salary Range

$120,000 - $190,000 USD The expected salary range above is applicable if the role is performed from Massachusetts and may vary for other locations (California, Illinois, New York). Actual salary may vary based on qualifications and experience.

Benefits

Tempus offers a full range of benefits, which may include incentive compensation, restricted stock units, medical and other benefits depending on the position.

Massachusetts Applicants

It is unlawful in Massachusetts to require or administer a lie detector test as a condition of employment or continued employment.

Equal Opportunity Employer

We are an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status.

Skills

Oncology
Genomic Testing
NGS
ctDNA
Medical Science Liaison
Clinical Research
Presentation Skills
Communication Skills
KOL Engagement
Precision Medicine

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters
2015Year Founded
$894.9MTotal Funding
IPOCompany Stage
AI & Machine Learning, Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Relocation Assistance
Company Equity
Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.
Ambry Genetics acquisition could pose financial risks if synergies aren't realized.
Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.
Their platform aids in personalized treatment decisions for cancer patients.
Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.
Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.
Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI